Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Trading Statement

17 Jan 2024 07:00

RNS Number : 8941Z
Galliford Try Holdings PLC
17 January 2024
 

Galliford Try Holdings plc

Trading Update

Wednesday 17 January 2024

 

 

Galliford Try Holdings plc, the UK construction group, today provides an update on trading for the half year period from 1 July 2023 to 31 December 2023. The Group expects to announce its results for the half year on Wednesday 6 March 2024.

 

Update on Current Trading

 

The Group is performing well, with strong momentum throughout the first six months of the current financial year, and continues to make good progress against its Sustainable Growth Strategy.

Trading is ahead of the prior year period and the Board's expectations, which were previously increased at the time of the full year results in September 2023. With good visibility over the second half, revenue for the full financial year is now expected to be approximately 5 per cent. ahead of current market expectations1, with an equivalent increase in expected profit before tax.

We are pleased with our recent acquisition of AVRS Systems in November 2023, and the progress of the integration of this specialist business in our growing Environment division. Together with our acquisitions of Ham Baker and MCS at the start of the last financial year, the Environment division is developing its adjacent market strategy as planned.

 

1 The range of analysts' forecasts for the year ended 30 June 2024, based on forecasts at 12 January 2024, is £1,435m to £1,490m for revenue and £25.2m to £28.1m for pre-exceptional profit before tax.

Strategic Update

 

Given the excellent progress to date against the Group's Sustainable Growth Strategy, the Board expects to update its strategic targets to 2030 during the second quarter of 2024.

Balance Sheet

 

The average month-end cash for the six months ended 31 December 2023 was circa £149m (year to 30 June 2023: £135m) and period-end cash at 31 December 2023 was circa £209m (31 December 2022: £196m). The Group continues to maintain a portfolio of PPP assets and has no pensions liabilities and no debt or associated covenants.  

 

The Group's strong balance sheet supports our ability to secure high quality contracts and frameworks, attract a highly skilled supply chain and continue to invest in the business.

 

Order Book and Outlook

 

The Group's order book of £3.7bn (31 December 2022: £3.5bn) remains predominantly in long term frameworks and provides good visibility of future workload, well beyond the current financial year. We continue to see a robust pipeline of opportunities across our chosen sectors, supported by our strong track record and focus on the public and regulated sectors alongside high-quality private clients.

 

We recently announced our appointment to build the £87m new build-to-rent development at Brent Cross Town, north London for Related Argent and Invesco Real Estate, our second appointment on this development. In the first half of the year our Building business was also appointed to undertake the £72m remodelling and refurbishment of Adelaide House in central London and our Investments and Building businesses signed contracts with a major build to rent operator for a £52m development in Cardiff.

 

Capital Allocation

 

In September 2022, having reviewed the Group's strong cash performance and ongoing capital requirements the Group launched a share buyback programme of up to a maximum of £15m. On 17 November 2023 we announced the completion of the share buyback programme with a total of 8,404,148 shares repurchased and subsequently cancelled, representing approximately 7.5 per cent. of issued share capital.

 

Board

 

As previously announced Andrew Duxbury, Group Finance Director, will leave the Group during the year. The Group is making good progress on securing Andrew's replacement and an update will be provided in due course. Also, as previously announced, Marisa Cassoni, Non-executive Director and Chair of the Audit Committee, was appointed Senior Independent Director with effect from 1 November 2023

 

 

Bill Hocking, Chief Executive, commented:

 

"Galliford Try continues to perform strongly and consistently, and our performance in the first half of the financial year provides increased confidence for the full year.

 

We are pleased with our recent acquisition of AVRS Systems, complementing our existing operations and acquisitions of specialists Ham Baker and MCS Control Systems, further adding to our ability to provide enhanced specialist services to our water sector and related clients. We have excellent people and project teams, a strong balance sheet and high-quality carefully selected order book in our chosen sectors. 

 

We are encouraged by the performance and momentum in the business and our expectations for the full year to June 2024 have improved accordingly."

 

A conference call for Analysts and Investors will be held at 09:00am UKT today, Wednesday 17 January 2024.

Dial in: (Toll-Free): +44 800 358 1035 or (Local): +44 20 3936 2999

Access Code: 762981

 

For further enquiries please contact:

 

Galliford Try

Bill Hocking, Chief Executive

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel & Company Secretary

01895 855001

Teneo 

James Macey White

 

 

020 7353 4200

 

 

Note to Editors

Galliford Try is a trading name of Galliford Try Holdings plc, a leading UK construction group listed on the London Stock Exchange. Operating as Galliford Try and Morrison Construction, the group carries out building and infrastructure (environment and highways) projects with clients in the public, private and regulated sectors across the UK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLGDBSXBDGSL
Date   Source Headline
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20265:10 pmRNSTotal Voting Rights
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20254:20 pmRNSHolding(s) in Company
18th Dec 20254:20 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 202510:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20253:00 pmRNSDirector/PDMR Shareholding
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20254:00 pmRNSTransaction in Own Shares - Replacement
19th Nov 20254:00 pmRNSTransaction in Own Shares - Replacement
19th Nov 20254:00 pmRNSTransaction in Own Shares - Replacement
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20253:00 pmRNSResult of AGM
13th Nov 20257:00 amRNSAGM Statement
7th Nov 202510:00 amRNSDirector/PDMR Shareholding
3rd Nov 20254:15 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.